Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

The ABCG2 gene variant increases the risk of high uric acid and cholesterol, especially in overweight or obese young Mexican males.

A specific gene change in APCDD1 increases the risk of hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Lack of a key enzyme causes severe skin issues and death in mice.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Ceramide synthase 4 is essential for maintaining skin barrier health.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

Genetic factors in PCOS are complex, with potential influences from the MC4R gene.

The PIP5K1A gene helps cashmere growth in goats by promoting cell proliferation, and melatonin boosts its expression.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Genetic variations may affect how well finasteride works for BPH patients.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Gene variation affects prostate issues and hair loss.